Centre for Commercialization of Cancer Immunotherapy is to Accelerate the discovery, commercialization, and access to Cancer Immunotherapy.
Centre for Commercialization of Cancer Immunotherapy has raised $3.4M in total funding. The most recent round was Grant. The last funding was announced in November 2023.
Centre for Commercialization of Cancer Immunotherapy's investors include Canada Economic Development for Quebec Regions.
Centre for Commercialization of Cancer Immunotherapy is headquartered in Montréal, Canada.
Centre for Commercialization of Cancer Immunotherapy is to Accelerate the discovery, commercialization, and access to Cancer Immunotherapy.
Centre for Commercialization of Cancer Immunotherapy is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Centre for Commercialization of Cancer Immunotherapy — Funding & Investors." VCBacked, November 13, 2023, https://www.vcbacked.co/company/centre-for-commercialization-of-cancer-immunotherapy. Accessed September 30, 2026.
VCBacked. (2023). Centre for Commercialization of Cancer Immunotherapy — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/centre-for-commercialization-of-cancer-immunotherapy
{{cite web |title=Centre for Commercialization of Cancer Immunotherapy — Funding & Investors |url=https://www.vcbacked.co/company/centre-for-commercialization-of-cancer-immunotherapy |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated